Literature DB >> 6806486

Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma.

D F Paulson, W A Cline, R B Koefoot, W Hinshaw, S Stephani.   

Abstract

This study was undertaken to determine the disease control and survival advantage of either extended field megavoltage irradiation or delayed androgen ablation in a randomized clinical trial. Comparison of the 2 treatments, using either time-to-first evidence of treatment failure or survival, demonstrates an advantage to extended field radiation.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6806486     DOI： 10.1016/s0022-5347(17)54136-1

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


  3 in total

1.  External radiation therapy of localized prostatic cancer.

Authors:  E K Reddy; S Giri; C M Mansfield
Journal:  J Natl Med Assoc       Date:  1984-01       Impact factor: 1.798

Review 2.  [Locally advanced prostate carcinoma (T2b-T4 N0) without and with clinical evidence of local progression (Tx N+) with lymphatic metastasis. Is radiotherapy for pelvic lymphatic metastasis indicated or not?].

Authors:  T Wiegel; W Hinkelbein
Journal:  Strahlenther Onkol       Date:  1998-05       Impact factor: 3.621

Review 3.  Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma.

Authors:  J L Mohler; B T Williams; I M Thompson; M E Marshall
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.